Latest Convertible Notes News

Neometals has cut its annual loss and sharpened its portfolio, but Deloitte has warned of a material uncertainty over the company’s ability to continue as a going concern. The miner says it may need about A$5 million in additional funding from December while pursuing unpaid placement proceeds from Omaha Value Holdings.

Noxopharm has completed its first-in-human safety trial for SOF-SKN and advanced the wider Sofra platform, but its annual report flags a material uncertainty over funding. The biotech ended June with A$293,573 in cash, net liabilities of A$3.65 million and a need for additional capital.

Clime Investment Management lifted FY26 net profit by 57% and nearly tripled net tangible assets after selling, closing or transferring several businesses. But KPMG qualified its audit opinion over evidence supporting millions of dollars in CAM-related revenue and receivables.

WIN Metals is positioning Radio as a potential near-term gold operation, but its A$1.99 million cash balance remains far below the estimated A$19 million funding requirement. Deloitte has highlighted a material uncertainty over the company’s ability to continue as a going concern.

Core Lithium has moved Finniss into the next phase of its restart, producing first spodumene concentrate and targeting an initial shipment in the December quarter. The company ended September with A$199.7 million in cash, while BP33 development and high-grade exploration continued in parallel.

Promisia Healthcare has maintained group care occupancy at 96%, above its 95% target, while completing the Chatswood acquisition and preparing to potentially accelerate full ownership of Golden View Village. FY27 underlying EBITDAF guidance of at least $8.0 million remains unchanged for the existing portfolio, with updated guidance due in November.

Volt Resources has secured a $1.5 million placement to fund its Alabama high-purity graphite refinery study, advance pilot work and reduce debt. Almost half the raise is subscribed by two directors, although their participation still requires shareholder approval.

Memphasys has reported record September-quarter invoiced revenue of A$211,000 as its Felix fertility device moves into more international markets. The commercial progress comes alongside A$3.5 million in funding, but the loan still requires shareholder approval for conversion into notes.

Carma delivered a much larger operation in FY26, with revenue up 59% and gross profit doubling, but the online used-car retailer remains deeply loss-making. Its next test is converting new sourcing and reconditioning capacity into faster inventory turnover and lower cash burn.

Peninsula Energy’s low-pH uranium restart delivered stronger grades but failed to move enough solution through its Lance wellfields, forcing a guidance withdrawal and a US$50.1 million impairment. The company has fresh funding, but its auditor has warned of material uncertainty over its ability to continue as a going concern.

Volt Resources securities will resume trading after the company outlined a funding plan worth approximately A$6.912 million and confirmed its ongoing ASX compliance. The restart comes with two Tanzanian mining licences cancelled, limited reported cash and a proposed A$1.5 million capital raising yet to be structured.

Clime Capital delivered a sharply stronger FY26 result, with after-tax profit rising to $10.3 million and dividends maintained. But KPMG qualified its audit after failing to obtain sufficient evidence for $36.2 million of unlisted unit trust valuations and related income and fees.